Texas-based MedCognitics has received FDA 510(k) clearance for its AI-powered breast cancer screening software QmTRIAGE.
QmTRIAGE uses AI to analyze 2D full-field digital mammography screenings and flags suggestive abnormalities for radiologist review.
MedCognetics software improves early detection of breast cancer using datasets collected from de-identified clinical data from UT Southwestern Medical Center in Dallas and intellectual property from UT Dallas’ Quality of Life Technology Laboratory To do.
UT Southwestern Medical Center and UT Dallas own shares in the company.
“MedCognetics is partnering with both the University of Texas at Dallas and the University of Texas Southwestern Medical Center (UTSW) to address these disparities by leveraging our technology to improve outcomes for various patient groups. In addition to this, MedCognetics CEO Debasish Nag said in a statement that the company’s software’s high detection accuracy reduces review times by radiologists.
the bigger trend
tech giant In a 2020 study published in Nature, Google developed an AI-based mammography technology that reduces false-positive and false-negative rates and outperforms radiologists.
Last month, a medical technology company iCAD has announced that it will incorporate Alphabet’s mammography AI technology into its breast imaging solutions, thanks to a strategic development and commercialization agreement.
As the use of AI in healthcare grows, experts have communicated the importance of keeping organizations safe. By including individuals with diverse backgrounds in the dataset, no bias is present in the data.
Research published earlier this year Journal of the American Society for Medical Informatics He pointed out that an AI model that works well for one group of people may fail for another. Therefore, biases in AI and machine learning require a holistic approach that requires multiple perspectives to address.